Latest filing published 19 Aug 2015 for PERNIX THERAPEUTICS HOLDINGS, INC., €36k.
Insider track record
No signal scores available.
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Douglas Drysdale: trading record in brief
Douglas Drysdale discloses dealings in Pernix Therapeutics Holdings, Inc. to SEC (Form 4). In total, 4 filings cover trades dated from 8 August 2014 to 18 August 2015.
Every open-market trade on record is a purchase: 2 purchases worth €126k, and no sale. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Other entries cover 1 option exercise. In 2015 alone, the filings show 2 purchases and no sales.
The record was last updated on 19 August 2015 with an open-market purchase (€36k) in Pernix Therapeutics Holdings, Inc. The median gap between a trade and its publication by SEC (Form 4) is 3 days. For comparison, the SEC allows two business days to file a Form 4. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Douglas Drysdale
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 8,500 shares@ US$4.69Common StockSEC:0001354488-15-003977:0Canonical exit: 16 Nov 2015 (T+90)
- 16,000 shares@ US$6.40Common StockSEC:0001354488-15-002152:0Canonical exit: 4 Aug 2015 (T+90)
- 187,500 shares@ US$2.09Common StockSEC:0001354488-14-004055:0
- 106,839 shares@ US$6.67Common StockSEC:0001354488-14-004055:1
4 of 4 declarations
